shutterstock_1277801254_hafakot
hafakot / Shutterstock.com
1 May 2019Big Pharma

Sandoz and EirGenix to market Herceptin biosimilar

A division of  Novartis has entered into an agreement with Taiwan-based  EirGenix to market a medicine which treats some cancer tumours.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
12 March 2019   Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.